Business Angels Switzerland (BAS)
Angel_Group/Syndicate
Active
Worb, Switzerland
90
1M
68
3.33
18
0.24
2
- Areas of investment
Summary
In 1997 was created Business Angels Switzerland (BAS), which is appeared as VC. The venture was found in Europe in Switzerland. The leading representative office of defined VC is situated in the Zu00fcrich.
The fund is generally included in 2-6 deals every year. Comparing to the other companies, this Business Angels Switzerland (BAS) performs on 24 percentage points less the average number of lead investments. Deals in the range of 1 - 5 millions dollars are the general things for fund. The real fund results show that this VC is 1 percentage points less often commits exit comparing to other companies. The high activity for fund was in 2015.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Business Angels Switzerland (BAS), startups are often financed by Foundation for Technological Innovation (FIT), investiere | Verve Capital Partners, GoBeyond. The meaningful sponsors for the fund in investment in the same round are GoBeyond, 4FO Ventures, 3wVentures. In the next rounds fund is usually obtained by investiere | Verve Capital Partners, GoBeyond, Zu00fcrcher Kantonal Bank.
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Switzerland. Among the most popular portfolio startups of the fund, we may highlight Piavita, Aspivix, AOT - Advanced Osteotomy Tools. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Information Technology.
Investor highlights
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 90
- Lead investments
- 18
- Exits
- 2
- Rounds per year
- 3.33
- Follow on index
- 0.24
- Investments by industry
- Health Care (26)
- Medical Device (16)
- Software (15)
- Biotechnology (13)
- Information Technology (12) Show 125 more
- Investments by region
-
- Switzerland (84)
- France (1)
- Belgium (1)
- Germany (3)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Avg. valuation at time of investment
- 115K
- Group Appearance index
- 0.42
- Avg. company exit year
- 4
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Perseo pharma | 01 Sep 2021 | Biotechnology | Seed | Switzerland, Basel-Stadt, Basel | |
WeCount | 15 Jul 2021 | Accounting, Financial Services | Seed | 109K | Switzerland, Vaud, Pully |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.